169.23 USD
↘ 1.64 (0.96%)LIVE (AS OF 11:34 AM EST)
Gilead Sciences Inc
GILDNASDAQ • USD
Market: OPEN
Gilead Sciences Inc (GILD) trades at $169.23 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place GILD at a fair price relative to peers.
Technical & fundamental data as of Nov 10, 2026.
Open?$169.45
High?$171.09
Low?$168.50
Prev. Close?$170.87
Volume?1.0M
Avg. Volume?6.4M
VWAP?$169.74
Rel. Volume?0.16x
Bid / Ask
Bid?$169.86 × 100
Ask?$179.00 × 300
Spread?$9.14
Midpoint?$174.43
Valuation & Ratios
Market Cap?211.9B
Shares Out?1.2B
Float?1.2B
Float %?99.7%
P/E Ratio?N/A
P/B Ratio?16.25
EPS?-$3.11
Dividend?1.94%
Ex-Dividend?2026-12-15
News
Profile
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
Themes
Employees
17.0K
Market Cap
211.9B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1992-01-22
Address
333 LAKESIDE DR
FOSTER CITY, CA 94404
Phone: (650) 574-3000
FOSTER CITY, CA 94404
Phone: (650) 574-3000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?91
Momentum?33
Short Sent.?57
Piotroski F-Score?3/9Weak
Altman Z-Score?3.95Safe
Confidence?63%Moderate
Short InterestModerate
Short % of Float?1.72%Low
Short Interest?21.3M
Days to Cover?3.2
Free Float1.2B
Avg Daily Volume6.7M
Settlement Date2026-10-30
Financial Health
Current Ratio?1.38Adequate
Quick Ratio?1.22Adequate
Cash Ratio?0.54Adequate
Debt/Equity?2.01High
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score53/100
P/E?N/A▾
P/B?16.25HIGH▾
Peers20
S&P10
P/S?6.84FAIR▾
Peers55
S&P18
P/FCF?15.4CHEAP▾
Peers78
S&P73
EV/EBITDA?71.4HIGH▾
Peers22
S&P3
EV/Sales?7.48HIGH▾
Peers55
S&P18
Returns & Efficiency
ROE?-29.6%WEAK▾
Peers13
S&P6
ROA?-7.5%WEAK▾
Peers11
S&P3
Cash Flow & Enterprise
FCF?$13.8B
Enterprise Value?$231.7B
Fundamentals ratios updated end of day